AI Signal & Stock Analysis · Strong ↑
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for CRL is Strong ↑; the stock is at $278.08 (-1.13% today); overbought (RSI 74); technical trend is Raise; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Strong ↑ |
|---|---|
| Price | $278.08 |
| Change today | -1.13% |
| RSI (14) | 73.96 |
| Relative volume | 0.46 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $13.3B |
| Forward P/E | 21.84 |
| 52-week high | -3.5% away |
| 52-week low | +92.7% above |
| Technical trend | RAISE-2026-05-28 |
| News sentiment | Positive |
| Sector | Healthcare-DiagResearch |
| Next earnings | 8/5/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns CRL (Charles River Laboratories International Inc) a Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
CRL's RSI is overbought (RSI 74). A reading above 70 is typically considered overbought and below 30 oversold.
CRL is trading about 3% below its 52-week high and 93% above its 52-week low as of Aug 14 2026, 1:04 PM.
CRL's next earnings date is 8/5/2026 8:30:00 AM.
CRL is classified under Healthcare-DiagResearch in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.